Temozolomide is additive with cytotoxic effect of irradiation in canine glioma cell lines

BACKGROUND: Similar to human glioblastoma patients, glial tumours in dogs have high treatment resistance and a guarded prognosis. In human medicine, the addition of temozolomide to radiotherapy leads to a favourable outcome in vivo as well as a higher antiproliferative effect on tumour cells in vitr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tresch, Nina Simona, Fuchs, Daniel, Morandi, Luca, Tonon, Caterina, Rohrer Bley, Carla, Nytko, Katarzyna J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604143/
https://www.ncbi.nlm.nih.gov/pubmed/34477324
http://dx.doi.org/10.1002/vms3.620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604143/
https://www.ncbi.nlm.nih.gov/pubmed/34477324
http://dx.doi.org/10.1002/vms3.620

Ejemplares similares